Achieve Life Sciences Inc (ACHV)
Healthcare
Biotechnology
6.30 $
-1.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Achieve Life Sciences Inc (ACHV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -49 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -17 | -9.1 | -30 | -9.1 | -11 | -15 | -13 | -29 | -38 | -24 | -30 | -49 | |
| 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | |
| 3.9 | 2.3 | 1.6 | 0.3 | 0.9 | 1.2 | 1.3 | 2.2 | 3.3 | 3.4 | 5.3 | 8.8 | |
| -2.9 | 0.4 | 1.0 | 4.5 | 0.9 | 1.2 | 1.3 | 2.2 | 3.3 | – | – | – | |
| 12 | 7.0 | -11 | -3.1 | 0.9 | -0.3 | -0.3 | 1.2 | 0.1 | -0.8 | 2.4 | -4.3 | |
| 0.1 | 0.4 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 5.4 | -2.1 | 11 | 13 | -5.1 | 5.0 | 0.0 | 0.0 | – | 0.0 | -22 | 6.1 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| 22 | 0.0 | 0.0 | 0.0 | 15 | 5.0 | 33 | – | 0.0 | 0.0 | 0.0 | 0.0 | |
| 2.9 | 3.6 | 0.2 | 1.9 | 15 | 15 | 15 | 15 | 0.0 | 0.0 | -8.3 | 5.0 | |
| 25 | 18 | 0.0 | 2.0 | 20 | 17 | 33 | 37 | 19 | 15 | 49 | 52 | |
| 13 | 6.4 | -19 | 5.5 | 4.0 | 7.1 | 19 | 7.2 | -18 | -9.2 | -2.8 | 8.2 | |
| -17 | -9.5 | -30 | -9.1 | -11 | -15 | -13 | -29 | -38 | -25 | -30 | -49 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.